<p>Oct 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including BCB Bancorp, Cadence Design Systems and Intellia Therapeutics, on Tuesday.</p>
<h3>HIGHLIGHTS</h3>
<ul>
<li>BCB Bancorp Inc  (BCBP.O) : KBW cuts target price to $9 from $9.5</li>
<li>Cadence Design Systems Inc  (CDNS.O) : JP Morgan raises target price to $405 from</li>
</ul>
<p>$390</p>
<ul>
<li>Intellia Therapeutics Inc  (NTLA.O) : RBC cuts to sector perform from outperform</li>
<li>Plymouth Industrial REIT Inc  (PLYM.N) : Colliers cuts to neutral from buy</li>
<li>WEC Energy Group Inc  (WEC.N) : RBC resumes coverage with sector perform rating;</li>
</ul>
<p>PT $131 Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.</p>
<ul>
<li>1St Source Corp  (SRCE.O) : D.A. Davidson raises target price to $69 from $67</li>
<li>Ameren Corp  (AEE.N) : &gt;: RBC initiates coverage with sector perform rating; PT $119</li>
<li>American Airlines  (AAL.O) : TD Cowen raises target price to $18 from $13</li>
<li>Amkor Technology Inc  (AMKR.O) : JP Morgan raises target price to $32 from $27</li>
<li>Aveanna Healthcare Holdings Inc  (AVAH.O) : Jefferies raises PT to $12.5 from $11</li>
<li>Avidity Biosciences Inc  (RNA.O) : RBC cuts to sector perform from outperform</li>
<li>Avidity Biosciences Inc  (RNA.O) : RBC raises target price to $72 from $61</li>
<li>BCB Bancorp Inc  (BCBP.O) : KBW cuts target price to $9 from $9.5</li>
<li>Bed Bath &amp; Beyond Inc  (BBBY.N) : Jefferies cuts target price to $9 from $9.5</li>
<li>Biomarin Pharmaceutical Inc  (BMRN.O) : RBC cuts target price to $66 from $70</li>
<li>Boot Barn Holdings Inc  (BOOT.N) : Seaport Research Partners cuts to neutral from buy</li>
<li>Byline Bancorp Inc  (BY.N) : Piper Sandler raises target price to $35 from $34</li>
<li>Cadence Bank  (CADE.N) : Piper Sandler cuts to neutral from overweight</li>
<li>Cadence Bank  (CADE.N) : Piper Sandler cuts target price to $40 from $41</li>
<li>Cadence Design Systems Inc  (CDNS.O) : JP Morgan raises target price to $405 from $390</li>
<li>Confluent Inc  (CFLT.O) : D.A.Davidson raises target price to $29 from $27</li>
<li>Confluent Inc  (CFLT.O) : Piper Sandler raises target price to $28 from $27</li>
<li>Confluent Inc  (CFLT.O) : Raymond James raises target price to $30 from $25</li>
<li>Confluent Inc  (CFLT.O) : TD Cowen raises target price to $27 from $24</li>
<li>Dominion Energy  (D.N) : RBC resumes coverage with sector perform rating; PT $70</li>
<li>Duke Energy Corp  (DUK.N) : RBC resumes coverage with sector perform rating; PT $143</li>
<li>Eastgroup Properties Inc  (EGP.N) : Jefferies raises target price to $200 from $194</li>
<li>Eastgroup Properties Inc  (EGP.N) : RBC raises target price to $183 from $182</li>
<li>Elevance Health  (ELV.N) : JP Morgan raises target price to $394 from $384</li>
<li>Entergy  (ETR.N) : RBC resumes coverage with outperform rating; price target $115</li>
<li>Evergy Inc  (EVRG.O) : RBC initiates coverage with outperform rating; price target $93</li>
<li>F5 Inc  (FFIV.O) : JP Morgan cuts target price to $295 from $320</li>
<li>F5 Inc  (FFIV.O) : Piper Sandler cuts target price to $277 from $355</li>
<li>First Hawaiian Inc  (FHB.O) : KBW raises target price to $29 from $28</li>
<li>Ford  (F.N) : Daiwa Capital Markets raises target price to $13 from $11</li>
<li>General Dynamics Corp  (GD.N) : JP Morgan raises target price to $380 from $345</li>
<li>Globe Life Inc  (GL.N) : KBW raises target price to $162 from $160</li>
<li>Intellia Therapeutics Inc  (NTLA.O) : RBC cuts to sector perform from outperform</li>
<li>Intellia Therapeutics Inc  (NTLA.O) : RBC cuts target price to $14 from $21</li>
<li>Lakeland Financial Corp  (LKFN.O) : KBW cuts target price to $66 from $68</li>
<li>Mohawk Industries Inc  (MHK.N) : JP Morgan raises target price to $152 from $140</li>
<li>Northfield Bancorp Inc  (NFBK.O) : KBW cuts target price to $12 from $13</li>
<li>OGE Energy Corp  (OGE.N) : RBC initiates coverage with sector perform rating; PT $51</li>
<li>Pinnacle West Capital Corp  (PNW.N) : RBC resumes coverage with sector perform rating</li>
<li>Pinnacle West Capital Corp  (PNW.N) : RBC resumes coverage with price target $99</li>
<li>Plymouth Industrial REIT Inc  (PLYM.N) : Colliers cuts to neutral from buy</li>
<li>PTC Therapeutics Inc  (PTCT.O) : Jefferies raises target price to $77 from $63</li>
<li>Southern Co  (SO.N) : RBC resumes coverage with sector perform rating; price target $107</li>
<li>Southwest Airlines Co  (LUV.N) : TD Cowen raises target price to $28 from $24</li>
<li>Universal Health Services  (UHS.N) : Leerink Partners ups target price to $284 from $276</li>
<li>W R Berkley Corp  (WRB.N) : TD Cowen cuts target price to $77 from $78</li>
<li>Wayfair Inc  (W.N) : TD Cowen raises target price to $74 from $68</li>
<li>WEC Energy Group Inc  (WEC.N) : RBC resumes coverage with sector perform rating; PT $131</li>
<li>Xcel Energy  (XEL.O) : RBC resumes coverage with outperform rating; price target $97</li>
</ul>

BCBP

CDNS

NTLA

<p>Wall Street analysts have updated their ratings and price targets for several U.S.-listed companies. BCB Bancorp's target price was cut to $9 by KBW, while Cadence Design Systems saw an increase to $405 from JP Morgan. Intellia Therapeutics was downgraded by RBC to sector perform with a target price reduction to $14. Other notable changes include target price increases for Ameren Corp, American Airlines, and Mohawk Industries, among others, reflecting a mix of upgrades and downgrades across various sectors.</p>

U.S. RESEARCH ROUNDUP- BCB Bancorp, Cadence Design Systems, Intellia Therapeutics